Dempsey James G. acquires over 65,000 shares in Frontier Group
Dempsey James G. reports acquisition of over 65,000 shares in Frontier Group Holdings, signaling ongoing confidence in the air transportation sector.
Mineralys Therapeutics reports director stock transactions
Mineralys Therapeutics, Inc. discloses stock transactions by director Kristine Peterson, indicating continued investment and confidence in the company.
CFO Mitchell Mark Christopher Reports Stock Transactions
CFO Mitchell Mark Christopher discloses stock transactions involving Frontier Group Holdings, revealing key financial maneuvers in the airline industry.
KKR Private Equity Conglomerate grants stock award to board member
KKR Private Equity Conglomerate LLC awarded stock to board member Kelly Marie Williams, reflecting its commitment to leadership incentives in the finance services sector.
Tillman's Corner Trust Sells 2.4 Million Shares of Falcon's Beyond
Tillman's Corner Trust has sold 2.4 million shares of Falcon's Beyond Global, marking a significant reduction in its ownership stake.
Elanco CFO VanHimbergen Acquires Deferred Stock Units
Elanco Animal Health CFO Robert M. VanHimbergen acquires deferred stock units, reflecting ongoing executive compensation strategies in the pharmaceutical sector.
Wang Yanjun Reports Share Sales Under Trading Plan
Wang Yanjun, CCO and General Counsel of Sea Ltd, reports multiple share sales under a trading plan, reflecting strategic financial management.
Gottwald reports significant Tredegar stock transaction
John D. Gottwald discloses a major stock transaction involving Tredegar Corp, reflecting changes in ownership dynamics in the manufacturing sector.
ADAR1 Capital Management Increases Stake in InMed Pharmaceuticals
ADAR1 Capital Management has reported increased stock holdings in InMed Pharmaceuticals, reflecting ongoing investment in the pharmaceutical sector.
Cytokinetics EVP Malik Ibraham Executes Stock Transactions
Malik Fady Ibraham of Cytokinetics acquires and sells shares, reflecting active management of his stock holdings in the pharmaceutical company.
Oil-Dri CEO Sells 27,125 Shares of Class B Stock
Daniel Jaffee, CEO of Oil-Dri Corp, sells 27,125 shares of Class B stock, reflecting active management of his equity holdings.
Choice Hotels CEO Dominic Dragisich Sells 1,227 Shares
Dominic Dragisich, President and CEO of Choice Hotels, sold 1,227 shares of common stock on October 20, 2026, under a planned trading strategy.
Mohamed Aneezal H Reports Share Transaction at CVGI
Mohamed Aneezal H, Chief Legal Officer at Commercial Vehicle Group, reports a share transaction, reflecting ongoing stock management and tax obligations.
Freshpet COO Baty Nicola J. Acquires 58,245 Shares
Baty Nicola J., COO of Freshpet, Inc., acquires 58,245 shares, strengthening his ownership stake and reflecting confidence in the company's future.
M&T Bank Vice Chairman Kevin J. Pearson Sells Shares
Kevin J. Pearson of M&T Bank Corp sold 2,000 shares of stock as part of a planned trading strategy, highlighting executive stock transactions in the banking sector.
Elanco CEO Simmons Acquires 120 Deferred Stock Units
Elanco's CEO Jeffrey N. Simmons acquires 120.04 deferred stock units, emphasizing executive compensation alignment with shareholder interests.
Uber board member John A. Thain acquires 350 shares
John A. Thain of Uber Technologies acquires 350 shares of common stock, highlighting corporate governance and transparency in the business services sector.
Invesco's Shannon A. Johnston Reports Share Transactions
Shannon A. Johnston of Invesco Ltd. reported significant share transactions, reflecting ongoing changes in executive compensation and stock ownership.
Sales Pedro Franco sells 50,000 shares of Energy Co of Parana
Sales Pedro Franco sold 50,000 shares of Energy Co of Parana, reflecting ongoing changes in ownership and potential impacts on investor perceptions.
Elanco's Modi Acquires Deferred Stock Units in Recent Filing
Rajeev A. Modi of Elanco Animal Health reports acquisition of deferred stock units, highlighting executive compensation trends in the pharmaceutical sector.